1726

506943

JBCHEPHARM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

J B CHEMICALS AND PHARMA Share Price Today

J B CHEMICALS AND PHARMA is currently trading at ₹2265.7, up by ₹13.0 from the previous close. The stock touched an intraday high of ₹2300.00 and a low of ₹2257.90 during the latest trading session. Over the past one year, J B CHEMICALS AND PHARMA has delivered a return of 32.0%, while the stock has declined 0.34% in the last one month.

J B CHEMICALS AND PHARMA performance

Today’s low Today’s high
₹ 2257.90 ₹ 2300.00
₹ 2249.20
52 week low 52 week high
₹ 1603.50 ₹ 2285.30
₹ 2249.20
Open Price ₹ 2276.50
Prev. Close ₹ 2252.70
Volume (Shares) 338270.00
Total traded value ₹ 7608.36
Upper Circuit ₹ 2703.20
Lower Circuit ₹ 1802.20
info

Investment Returns

Over 1 Month -0.34% Over 3 Months 3.97% Over 6 Months 21.63% Over 1 Year 32.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

J B CHEMICALS AND PHARMA fundamentals


  • Market cap (Cr) 36,120.90
  • P/E Ratio (TTM) 52.49
  • Beta 0.41
  • Book Value / share 251.47
  • Return on equity 18.18%
  • EPS (TTM) 42.56
  • Dividend yield 1.00%
  • Net profit/quarter (Cr) 96.54
info icon alternate text
  • Market cap (Cr) 36,168.30
  • P/E Ratio (TTM) 52.49
  • Beta 0.37
  • Book Value / share 251.47
  • Return on equity 18.18%
  • EPS (TTM) 42.56
  • Dividend yield 1.00%
  • Net profit/quarter (Cr) 96.54
info icon alternate text

J B CHEMICALS AND PHARMA Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 836.43
Operating Expense 691.39
Net Profit 96.54
Net Profit Margin (%) 11.54
Earnings Per Share (EPS) 6.05
EBITDA 177.99
Effective Tax Rate (%) 24.63
Particulars DEC 2025 (Values in Cr)
Revenue 990.91
Operating Expense 766.62
Net Profit 179.27
Net Profit Margin (%) 18.09
Earnings Per Share (EPS) 11.45
EBITDA 286.39
Effective Tax Rate (%) 25.66
Particulars SEP 2025 (Values in Cr)
Revenue 1022.65
Operating Expense 768.41
Net Profit 200.42
Net Profit Margin (%) 19.59
Earnings Per Share (EPS) 12.82
EBITDA 312.61
Effective Tax Rate (%) 25.35
Particulars JUN 2025 (Values in Cr)
Revenue 1039.90
Operating Expense 788.83
Net Profit 197.87
Net Profit Margin (%) 19.02
Earnings Per Share (EPS) 12.70
EBITDA 307.02
Effective Tax Rate (%) 25.32
Particulars MAR 2025 (Values in Cr)
Revenue 901.34
Operating Expense 715.69
Net Profit 149.80
Net Profit Margin (%) 16.61
Earnings Per Share (EPS) 9.63
EBITDA 244.51
Effective Tax Rate (%) 24.78
Particulars MAR 2026 (Values in Cr)
Revenue 3889.89
Operating Expense 3015.26
Net Profit 674.10
Net Profit Margin (%) 17.32
Earnings Per Share (EPS) 42.91
EBITDA 1084.01
Effective Tax Rate (%) 25.32
Particulars MAR 2025 (Values in Cr)
Revenue 3722.92
Operating Expense 2880.54
Net Profit 652.54
Net Profit Margin (%) 17.52
Earnings Per Share (EPS) 42.00
EBITDA 1052.68
Effective Tax Rate (%) 25.60
Particulars MAR 2024 (Values in Cr)
Revenue 3298.64
Operating Expense 2594.98
Net Profit 543.36
Net Profit Margin (%) 16.47
Earnings Per Share (EPS) 35.07
EBITDA 914.10
Effective Tax Rate (%) 26.40
Particulars MAR 2023 (Values in Cr)
Revenue 2884.16
Operating Expense 2365.77
Net Profit 388.89
Net Profit Margin (%) 13.48
Earnings Per Share (EPS) 50.29
EBITDA 673.33
Effective Tax Rate (%) 26.21
Particulars MAR 2022 (Values in Cr)
Revenue 2189.88
Operating Expense 1757.20
Net Profit 361.00
Net Profit Margin (%) 16.48
Earnings Per Share (EPS) 46.71
EBITDA 547.52
Effective Tax Rate (%) 23.40
Particulars MAR 2026 (Values in Cr)
Book Value / Share 259.05
ROE % 18.69
ROCE % 24.94
Total Debt to Total Equity 0.00
EBITDA Margin 27.49
Particulars MAR 2025 (Values in Cr)
Book Value / Share 220.54
ROE % 20.75
ROCE % 26.42
Total Debt to Total Equity 0.06
EBITDA Margin 27.31
Particulars MAR 2024 (Values in Cr)
Book Value / Share 188.36
ROE % 20.45
ROCE % 24.90
Total Debt to Total Equity 0.18
EBITDA Margin 26.81
Particulars MAR 2023 (Values in Cr)
Book Value / Share 320.55
ROE % 17.77
ROCE % 22.41
Total Debt to Total Equity 0.14
EBITDA Margin 22.41
Particulars MAR 2022 (Values in Cr)
Book Value / Share 276.15
ROE % 19.58
ROCE % 25.01
Total Debt to Total Equity 0.03
EBITDA Margin 24.04
Particulars MAR 2026 (Values in Cr)
Book Value / Share 251.48
ROE % 18.18
ROCE % 24.24
Total Debt to Total Equity 0.00
EBITDA Margin 27.87
Particulars MAR 2025 (Values in Cr)
Book Value / Share 216.94
ROE % 20.84
ROCE % 26.54
Total Debt to Total Equity 0.06
EBITDA Margin 28.28
Particulars MAR 2024 (Values in Cr)
Book Value / Share 185.98
ROE % 20.39
ROCE % 24.83
Total Debt to Total Equity 0.17
EBITDA Margin 27.71
Particulars MAR 2023 (Values in Cr)
Book Value / Share 315.65
ROE % 17.11
ROCE % 21.68
Total Debt to Total Equity 0.13
EBITDA Margin 23.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 272.21
ROE % 18.46
ROCE % 23.61
Total Debt to Total Equity 0.02
EBITDA Margin 25.00
Particulars MAR 2026 (Values in Cr)
Cash & Short Term Investments 145.87
Total Assets 4968.64
Total Liabilities 4968.64
Total Equity 4159.21
Share Outstanding 16
Price to Book Ratio 8.20
Return on Assets (%) 14.27
Return on Capital (%) 17.06
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 129.44
Total Assets 4273.77
Total Liabilities 4273.77
Total Equity 3433.31
Share Outstanding 15
Price to Book Ratio 7.48
Return on Assets (%) 15.43
Return on Capital (%) 19.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 95.53
Total Assets 3994.12
Total Liabilities 3994.12
Total Equity 2923.32
Share Outstanding 15
Price to Book Ratio 8.87
Return on Assets (%) 13.83
Return on Capital (%) 16.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 78.81
Total Assets 3553.87
Total Liabilities 3553.87
Total Equity 2480.35
Share Outstanding 7
Price to Book Ratio 6.24
Return on Assets (%) 11.53
Return on Capital (%) 13.53
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 58.52
Total Assets 2607.40
Total Liabilities 2607.40
Total Equity 2138.61
Share Outstanding 7
Price to Book Ratio 5.79
Return on Assets (%) 14.77
Return on Capital (%) 17.8
Particulars MAR 2026 (Values in Cr)
Cash & Short Term Investments 62.05
Total Assets 4823.49
Total Liabilities 4823.49
Total Equity 4037.70
Share Outstanding 16
Price to Book Ratio 8.20
Return on Assets (%) 13.97
Return on Capital (%) 16.7
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 90.56
Total Assets 4177.89
Total Liabilities 4177.89
Total Equity 3377.19
Share Outstanding 15
Price to Book Ratio 7.48
Return on Assets (%) 15.61
Return on Capital (%) 19.32
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 63.69
Total Assets 3913.63
Total Liabilities 3913.63
Total Equity 2886.26
Share Outstanding 15
Price to Book Ratio 8.87
Return on Assets (%) 13.88
Return on Capital (%) 16.83
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 55.76
Total Assets 3470.14
Total Liabilities 3470.14
Total Equity 2442.47
Share Outstanding 7
Price to Book Ratio 6.24
Return on Assets (%) 11.20
Return on Capital (%) 13.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 39.67
Total Assets 2538.06
Total Liabilities 2538.06
Total Equity 2103.66
Share Outstanding 7
Price to Book Ratio 5.79
Return on Assets (%) 14.22
Return on Capital (%) 16.95
Particulars MAR 2026 (Values in Cr)
Net Income 952.33
Cash from Operations 960.16
Cash from Investing -585.87
Cash from Financing -123.09
Net change in Cash -5.05
Free Cash Flow 1043.35
Particulars MAR 2025 (Values in Cr)
Net Income 887.39
Cash from Operations 1103.12
Cash from Investing -295.89
Cash from Financing -579.67
Net change in Cash 26.88
Free Cash Flow 1200.70
Particulars MAR 2024 (Values in Cr)
Net Income 751.50
Cash from Operations 933.09
Cash from Investing -403.83
Cash from Financing -385.48
Net change in Cash 11.29
Free Cash Flow 1059.96
Particulars MAR 2023 (Values in Cr)
Net Income 555.23
Cash from Operations 721.09
Cash from Investing -961.78
Cash from Financing 356.53
Net change in Cash 20.36
Free Cash Flow 793.65
Particulars MAR 2022 (Values in Cr)
Net Income 504.90
Cash from Operations 304.75
Cash from Investing 2.31
Cash from Financing -138.38
Net change in Cash 34.06
Free Cash Flow 367.62
Particulars MAR 2026 (Values in Cr)
Net Income 902.72
Cash from Operations 890.99
Cash from Investing -587.20
Cash from Financing -107.67
Net change in Cash -49.99
Free Cash Flow 971.12
Particulars MAR 2025 (Values in Cr)
Net Income 877.10
Cash from Operations 1076.87
Cash from Investing -289.92
Cash from Financing -574.26
Net change in Cash 19.84
Free Cash Flow 1172.94
Particulars MAR 2024 (Values in Cr)
Net Income 738.33
Cash from Operations 916.96
Cash from Investing -412.44
Cash from Financing -374.07
Net change in Cash 2.50
Free Cash Flow 1043.07
Particulars MAR 2023 (Values in Cr)
Net Income 527.03
Cash from Operations 717.23
Cash from Investing -955.88
Cash from Financing 343.40
Net change in Cash 16.16
Free Cash Flow 789.69
Particulars MAR 2022 (Values in Cr)
Net Income 471.29
Cash from Operations 274.22
Cash from Investing 4.17
Cash from Financing -137.85
Net change in Cash 13.42
Free Cash Flow 335.51
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 33.07 13.67 1.60 253.43 23.12 38.85
BLISS GVS PHARMA LTD 423.70 34.28 3.75 4482.28 118.35 462.70
CIPLA LTD. 1376.25 29.21 3.22 111179.71 1165.55 1672.20
FERMENTA BIOTECH LTD. 327.50 14.45 2.37 963.86 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.24 23.94 4.41 262.39 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 554.85 24.87 4.33 1604.11 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8383.40 109.49 24.01 20958.50 7630.00 10653.05
BLISS GVS PHARMA LTD 419.15 45.07 3.83 4434.14 118.35 462.70

J B CHEMICALS AND PHARMA shareholding pattern

Holding
13.48%
48.8%
16.33%
21.38%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

J B CHEMICALS AND PHARMA Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
2249.70 2.18 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 2184.70
  • 26 Days 2148.10
  • 10 Days 2174.60
  • 50 Days 2108.80
  • 12 Days 2171.70
  • 100 Days 2037.10
  • 20 Days 2158.60
  • 200 Days 1943.30
2213.97 PIVOT
First Support 2177.63 First Resistance 2237.83 Second Support 2153.77 Second Resistance 2274.17 Third Support 2117.43 Third Resistance 2298.03
RSI 59.55 ADX 34.33 MACD 23.58 Williams % R -41.00 Commodity Channel Index (CCI) 112.17
Date 2026-06-10 Week 160754.00 Same Day 192028.00 Month 181545.00
1 Year 0.41 3 Year 0.47
Over 1 Month
-0.34% down
Over 1 Year
32.00% down
Over 3 Months
3.97% down
Over 3 Years
27.18% down
Over 6 Months
21.63% down
Over 5 Years
23.46% down

J B CHEMICALS AND PHARMA Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
29 May 2026 9.3 Final 29 May 2026 Equity shares
11 Feb 2026 12.7 Interim 11 Feb 2026 Equity shares
30 Jul 2025 7.0 Final 30 Jul 2025 Equity shares
07 Feb 2025 8.5 Interim 08 Feb 2025 Equity shares
14 Aug 2024 6.75 Final 14 Aug 2024 Equity shares
16 Feb 2024 5.5 Interim 16 Feb 2024 Equity shares
17 Aug 2023 9.25 Final 17 Aug 2023 Equity shares
17 Feb 2023 8.5 Interim 18 Feb 2023 Equity shares
12 Aug 2022 8.0 Final 17 Aug 2022 Equity shares
23 Feb 2022 8.5 Interim 24 Feb 2022 Equity shares
01 Sep 2021 8.0 Final 02 Sep 2021 Equity shares
18 Feb 2021 8.5 Interim 22 Feb 2021 Equity shares
22 Sep 2020 1.0 Final 23 Sep 2020 Equity shares
03 Mar 2020 10.0 Interim 04 Mar 2020 Equity shares
14 Aug 2019 5.0 Final 16 Aug 2019 Equity shares
27 Aug 2018 2.0 Final 29 Aug 2018 Equity shares
11 Sep 2017 1.0 Final 13 Sep 2017 Equity shares
11 Aug 2016 0.5 Final 16 Aug 2016 Equity shares
17 Mar 2016 4.5 Interim 19 Mar 2016 Equity shares
06 Aug 2015 4.0 Final 08 Aug 2015 Equity shares
06 Aug 2015 10.0 Special 08 Aug 2015 Equity shares
04 Sep 2014 3.0 Final 06 Sep 2014 Equity shares
01 Aug 2013 3.0 Final 03 Aug 2013 Equity shares
19 Jul 2012 1.0 Final 21 Jul 2012 Equity shares
29 Aug 2011 40.0 Interim 31 Aug 2011 Equity shares
14 Jul 2011 2.0 Final 18 Jul 2011 Equity shares
15 Jul 2010 2.0 Final 19 Jul 2010 Equity shares
02 Jul 2009 1.0 Final 04 Jul 2009 Equity shares
03 Jul 2008 0.5 Final 05 Jul 2008 Equity shares
12 Jul 2007 1.5 Final 16 Jul 2007 Equity shares
13 Nov 2006 1.1 Interim 01 Jan 0001 Equity shares
Ex-Date Ex-Bonus Ratio
30 Oct 1998 05 Oct 1998 1:1
Ex-Date Old FV NEW FV Record Date
18 Sep 2023 2.0 1.0 18 Sep 2023
05 Apr 2005 10.0 2.0 12 Apr 2005
Dividend date Dividend amount Dividend type Record date Instrument type
29 May 2026 9.3 Final 29 May 2026 Equity shares
11 Feb 2026 12.7 Interim 11 Feb 2026 Equity shares
30 Jul 2025 7.0 Final 30 Jul 2025 Equity shares
07 Feb 2025 8.5 Interim 08 Feb 2025 Equity shares
14 Aug 2024 6.75 Final 14 Aug 2024 Equity shares
16 Feb 2024 5.5 Interim 16 Feb 2024 Equity shares
17 Aug 2023 9.25 Final 17 Aug 2023 Equity shares
17 Feb 2023 8.5 Interim 18 Feb 2023 Equity shares
12 Aug 2022 8.0 Final 17 Aug 2022 Equity shares
23 Feb 2022 8.5 Interim 24 Feb 2022 Equity shares
01 Sep 2021 8.0 Final 02 Sep 2021 Equity shares
18 Feb 2021 8.5 Interim 22 Feb 2021 Equity shares
22 Sep 2020 1.0 Final 23 Sep 2020 Equity shares
03 Mar 2020 10.0 Interim 04 Mar 2020 Equity shares
14 Aug 2019 5.0 Final 16 Aug 2019 Equity shares
27 Aug 2018 2.0 Final 29 Aug 2018 Equity shares
11 Sep 2017 1.0 Final 13 Sep 2017 Equity shares
11 Aug 2016 0.5 Final 16 Aug 2016 Equity shares
17 Mar 2016 4.5 Interim 19 Mar 2016 Equity shares
06 Aug 2015 4.0 Final 08 Aug 2015 Equity shares
06 Aug 2015 10.0 Special 08 Aug 2015 Equity shares
04 Sep 2014 3.0 Final 06 Sep 2014 Equity shares
01 Aug 2013 3.0 Final 03 Aug 2013 Equity shares
19 Jul 2012 1.0 Final 21 Jul 2012 Equity shares
29 Aug 2011 40.0 Interim 31 Aug 2011 Equity shares
14 Jul 2011 2.0 Final 18 Jul 2011 Equity shares
15 Jul 2010 2.0 Final 19 Jul 2010 Equity shares
02 Jul 2009 1.0 Final 04 Jul 2009 Equity shares
03 Jul 2008 0.5 Final 05 Jul 2008 Equity shares
12 Jul 2007 1.5 Final 16 Jul 2007 Equity shares
13 Nov 2006 1.1 Interim 01 Jan 0001 Equity shares
Ex-Date Ex-Bonus Ratio
30 Oct 1998 05 Oct 1998 1:1
Ex-Date Old FV NEW FV Record Date
18 Sep 2023 2.0 1.0 18 Sep 2023
05 Apr 2005 10.0 2.0 12 Apr 2005

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of J B Chemicals & Pharmaceuticals Ltd?

Answer Field

J B Chemicals & Pharmaceuticals Ltd share price is for NSE ₹ 2,265.70 & for BSE ₹ 2,266.55 as on Jun 12 2026 01:12 PM.

What is the Market Cap of J B Chemicals & Pharmaceuticals Ltd Share?

Answer Field

The market cap of J B Chemicals & Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 12 2026 01:12 PM.

What is the 52 Week High and Low of J B Chemicals & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of J B Chemicals & Pharmaceuticals Ltd for NSE is ₹ 2,285.30 and ₹ 1,603.50 and for BSE is ₹ 2,284.95 and ₹ 1,603.05.

What is 1 year return for J B Chemicals & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 32.00%.

What is the P/E Ratio of J B Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Jun 12 2026 01:12 PM the price-to-earnings (PE) ratio for J B Chemicals & Pharmaceuticals Ltd share is 52.49.

What is the PB ratio of J B Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Jun 12 2026 01:12 PM, the price-to-book (PB) ratio for J B Chemicals & Pharmaceuticals Ltd share is 251.47.

How to Buy J B Chemicals & Pharmaceuticals Ltd Share?

Answer Field

You can trade in J B Chemicals & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy J B Chemicals & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy J B Chemicals & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “J B Chemicals & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|